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Summary
Freshly isolated B lymphocytes from patients infected with human immunodeficiency virus (HIV),
in contrast to B cells from normal controls, were shown to induce viral expression in two cell
lines: ACH-2, a T cell line, and Ul, a promonocytic cell line, which are chronically infected
with HIV, as well as in autologous T cells. In 10 out of 10 HIVinfected individuals with
hypergammaglobulinemia, spontaneous HIV-inductive capacity was found with highly purified
peripheral blood B cells, whereas peripheral blood or tonsillar B cells from six healthy, HIV
negative donors did not induce HIV expression unless the cells were stimulated in vitro. The
induction of HIV expression was observed in direct coculture experiments of B lymphocytes
and HIVinfected cells, and could also be mediated by supernatants from cultures of B cells.
Significantly higher amounts of interleukin 6 (IL6) and tumor necrosis factor a (TNF-a) were
detected in the B cell culture supernatants from HIVinfected patients with hypergammaglobulinemia
(IL-6: z = 536 pg/ml; TNF-a: x = 493 pg/ml), as compared with normal uninfected controls
(IL-6: x = 18 pg/ml; TNF-a: z = 23 pg/ml). Antibodies against these cytokines abolished
the HIV-inductive capacity of B cells. We conclude that in vivo activated B cells in HIVinfected
individuals can upregulate the expression of virus in infected cells by secreting cytokines such
as TNF-a and IL6, and, therefore, may play a role in the progression of HIV infection.
After infection with the HIV, the causative agentofAIDS,
variable periods ofclinical latency measured in years are
observed in most infected individuals, suggesting that a state
of low-level, persistent infection is established (reviewed in
reference 1). To delineate the mechanisms regulating virus
expression, two chronically HIVinfected cell lines, U1(pro-
monocytes) and ACH-2 (T cells), which constitutively ex-
press low to undetectable levels of virus, were established in
our laboratory (2, 3) . It has been demonstrated that cytokines
such as TNF-a (4) and IL6 (5) upregulate the expression
of HIV in U1 (both cytokines) and ACH-2 (TNF-a only)
cells, as well as in other cells or cell lines of T lymphocyte
(6) and monocyte (5) origin.
An early and consistent feature of HIV infection is poly-
clonal B cell activation, characterized by hypergammaglob-
ulinemia (7), and increased numbers of spontaneous Ig-
secreting cells in the circulation (7, 8). Despite this state of
hyperactivity, certain B cell functions such as in vitro response
to Staphylococcus aureus Cowan strain 1 (SAC) or PWM and
antibody production after antigenic challenge (7) are impaired
in HIVinfected individuals.
Several recent reports have demonstrated that in vitro acti-
vated normal B cells produce TNF-a (9) and IL-6 (10). In
vivo production of 11,6 by germinal center B cells of hyper-
plastic lymph nodes from patients with Castleman's disease
(11) suggested that activated B lymphocytes may be an im-
portant source ofcytokine productionin vivo. Therefore, we
investigated the capacity ofB lymphocytes from HIV-infected
individuals to secrete TNF-a and IL-6, and to induce HIV
expression in infected cells.
Materials and Methods
Purification and Activation ofB Cells.
￿
B cell-enriched popula-
tions from tonsils and lymph nodes were obtained as previously
described (12). PBL were obtained from 10 HIVseropositive indi-
viduals with hypergammaglobulinemia and six healthy seronega-
tive donors by Ficoll-Hypaque (Pharmacia Fine Chemicals, Pis-
cataway, NJ) gradient centrifugation. T lymphocytes were removed
as described (12), and the remaining cells were sorted for the B
cell-specific antigen CD20 (Leu-16) with an Epics C-flow cytom-
eter (Coulter Electronics Inc., Hialeah, FL). These preparations
were routinely >98% Leu-16 (B cell) positive, and <1% Leu-M3
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1-5(monocyte), <1% Leu-llb (NK cells), and <1% Leu-5b (CD2,
SRBC receptor on T cells) positive as determined by FRCS anal-
ysis . All mAbs were purchased from Becton Dickinson & Co .,
Mountain View, CA) .
B cells were cultured in the absence or presence of 0.01%
formalin-inactivated SAC (Bethesda Research Laboratories, Gaithers-
burg, MD) and 100 U/ml of rIL2 (Cetus Corp., Emeryville, CA)
at 106 cells/ml . Overnight culture supernatants were collected,
filtered through an0 .45-Am low protein binding filter (Millipore
Continental Water Systems, Bedford, MA), and stored at -70°C
until use . Supernatants from unstimulated and activatedB cell cul-
tures were tested for the presence of TNF-cx and IL-6 by commer-
cially available ELISA kits .
Coculture System .
￿
100 1A of chronically HIVinfected cells (5
x 105/ml) or 100 P,1 of autologous T cells (106/ml) and 100 ul
of various concentrations ofB lymphocytes (10, 5, 2 .5, 1.25, and
0.5 x 105/ml) resuspended in RPMI 1640 + 10% FCS were
combined in 96-well plates . Supernatants were collected every 2 d
and stored at -70°C . U1 and ACH-2 cells were also incubated
at thesame concentration in the presence or absence ofeither PMA
(10 -7 M; Sigma Chemical Co., St . Louis, MO), 100 U/ml of
rTNF-cx (Genzyme, Boston,MA), 100U/ml ofrIL6 (Amgen Bio-
logicals, Thousand Oaks, CA), or 25% (vol/vol) B cell superna-
tants . In the neutralization experiments, goat polyclonal andmurine
monoclonal anti-IL6 antibodies (R&D Systems, Minneapolis, MN)
and a monoclonal antiTNF-cx antibody (Olympus, Corporation
of America, New Hyde Park, NY) were added alone or in combi-
nation toB cell supernatant-enriched mediaand incubated at room
temperature for 30 min before addition to the HIV-infected cells.
In coculture experiments, the antibodies were directly added at the
beginning of the cocultivation with similar results .
Virus Detection .
￿
The presence ofHIV reverse transcriptase (RT)
activity in the culture supernatants was measured by the method
of Willey et al . (13) . p24 antigen in the culture supernatant was
detected with acloneELISA-based kit (Coulter Immunology, Hi-
aleah, FL) .
Results
Activated B Cell Supernatants Induce HIV Expression in In-
fected Cell Lines. In initial studieswith fresh tonsillar B cells,
obtained from HIVseronegative individuals, TNF-cx and IL6
secretion couldbe inducedupon stimulation with SAC/IL-2
(data not shown) . Supernatants from SACAL2-stimulated
B cells were then tested for their HIV-inductive capacity using
U1 or ACH-2 cells, and thehighest activity was present after
24 h (Fig . 1 A) . Because TNF-cx and IL-6 are known to in-
duce HIV expression in a variety of infected cells, including
U1 (both cytokines [4, 5]) and ACH-2 (TNF-cx only [4]), these
observations suggested that the secreted cytokines represented
themajor viral-inductive components ofB cell supernatants .
To further confirm this hypothesis, supernatants fromBcells
stimulated with SAC/IL-2 were preincubated with antiTNF-u
and/or anti-IL6 antibodies before their addition to U1 or
ACH-2 cells . As shown in Fig . 1 B, the antiTNF-a anti-
body suppressed HIV expression in bothACH-2 andU1 cells
incubated with supernatants from normal activated B cells .
The anti-IL-6 antibody reducedB cell-dependent HIV ex-
pression in U1 cells, whereas it hadno effect onACH-2 cells,
as previously reported (6).Acombination of both antibodies
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Induction of HIV expression by supernatants from activated
normal B cells. (A) Effect ofsupernatants collected at different times from
SAC/11,2-activated tonsillar B cells on the chronically HIVinfected pro-
monocyte cell (Ul) andT cell (ACH-2) line. Cells were incubated in media
containing 50% filtered B cell supernatant. Reverse transcriptase (RT) ac-
tivity was measured at its peak induction (4 d post-stimulation) . (B) Neu-
tralization of supernatants from in vitro activated B cells (Act . B cells)
by anticytokine antibodies. B cell supernatant-enriched media were prein-
cubated for 30 min with the antibodies before adding to the infected U1
or ACH-2 cells . RT activity was measured after 4 d (peak activity) .
completely blocked the virus production in U1 cells stimu-
lated with B cell supernatants (Fig. 1 B) .
In Vitro Activated NormalB Cells Induce HIV Expression in
a Coculture System. Having established that B cell-derived
cytokines can induce HIV expression in chronically infected
cells, we investigated whether a similar effect could be seen
in a direct cell-to-cell coculture system . When U1 or ACH-2
cells were cocultivated with SACAL2 activated B cells, the
peak of RT production was usually seen on the fourth day
ofculture (data notshown) . In comparative experiments, the
direct B cell coculture was found to be more sensitive than
incubation with B cell supernatants in terms ofHIV induc-
tion in U1 and ACH-2 cells . Therefore, this approach was
used in all subsequent experiments .
In Vivo ActivatedB cells From HIVinfected Individuals Induce
HIV Expression in a Coculture System . Having demonstrated
that in vitro activation of B lymphocytes can induce HIV
expression, we addressed the question whether in vivo acti-
vatedB cells from HIV-infected individuals with hypergam-
maglobulinemia can exert similar effects . In all 10 patientsTable 1 .
￿
Laboratory Findings ofHIV-infected individuals and
Seronegative Healthy Donors
" Three of the HIV-infected individuals were asymptomatic, two had
AIDS-related complex, and five had AIDS.
t TNF-cr and IL-6 were measured in unstimulated overnight cultures
from highly purified peripheral blood Blymphocytes using commercially
available ELISA kits .
with IgG levels > 1,600 mg/dl investigated to date (Table
1), highly purified peripheral blood B lymphocytes (>99%
CD20+) secreted significant amounts of TNF-a and IL-6
(Table 1). When these cells were cocultivated with U1 or
ACH-2 cells, they induced HIV expression without any in
vitro stimulation (Fig. 2) . In contrast, peripheral blood B
cells from six healthy seronegative donors secreted low to
undetectable levels of TNF-a and IL-6 (Table 1) and failed
to induce HIV expression without in vitro stimulation (Fig.
2). The HIV-inductive effect ofpatients' B cells in these cocul-
ture systems was also blocked by antiTNF-oz and/or anti-IL-6
antibodies as observed with normal, in vitro activated B cells
(data not shown). In two patients who underwent axillary
lymphadenectomy, B cells obtained from the lymph node were
also found to be in vivo activated since they secreted high
levels of cytokines and induced HIV expression. This sug-
gests that B cell activation is not confined to circulating cells,
but can occur also in lymphoid tissue where B cells can be
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Figure 2.
￿
Blymphocytes from HIVinfected individuals but not normal
donors induce HIVexpression. Peripheral blood B lymphocytes from HIV
seropositive individuals with hypergammaglobulinernia (n = 10) and normal
donors (n = 6) were cocultivated with HIV-infected cell lines (Ul or ACH-
2) at a 1:1 ratio for 4 d without any stimulants.
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Induction of HIV expression in an unstimulated autologous
coculture system. Separated B and T cells from the lymph node (patient
1) or peripheral blood (patients 2 and 3) were cocultured at a ratio of 1:1.
Supernatant was collected every 2 d and assayed for p24 antigen (closed
symbols, B + T coculture; open symbols; Tcells alone).
in close cell-to-cell contact with HIVinfected cells. Finally,
in an unstimulated coculture system of autologous B and T
cells (optimal ratio, 1:1) from the same patient, increasing
amounts of p24 antigen, which peaked around day 6, were
detected in the culture supernatants (Fig. 3). This induction
was clearly B cell dependent, as limiting dilution experiments
revealed (data not shown). No increase of p24 release was
observed if T cells were cultured in the absence of autolo-
gous B cells.
The present study has demonstrated that activated B lym-
phocytes, which are present in the circulation of HIV-infected
individuals with hypergammaglobulinemia, secrete TNF-a
and IL-6 and induce HIV expression in chronically infected
cells, as well as in autologous infected T cells. Given the con-
sistent finding of polyclonally activated B cells in HIV-infected
individuals (7), this study strongly suggests a potentially im-
portant role ofcytokine production by these activated B cells
in the induction of HIV expression in infected cells. IL-6 and
TNF-a production in HIV infection has been attributed
mainly to monocytes/macrophages (14, 15), and although
the reported levels of cytokines produced by unstimulated
overnight cultures of monocytes/macrophages from HIV
infected individuals were four- to eightfold higher than the
amounts of IL-6 and TNF-a secreted by B cells, it must be
taken into consideration that the adherence of monocytes to
tissue culture flasks may increase cytokine productionin vitro,
as well as the fact that there is a much greater density of
B cells compared with macrophages in lymph nodes of pa-
tients with HIV-related follicular hyperplasia (16). Our finding
that virus can be induced in an unstimulated, autologous B/T
cell coculture system is a close correlate to the possible inter-
action of these two cell types in vivo in lymphatic tissue.
Previous reports have described that HIV (17), HIV-derived
proteins, or synthetic peptides from the gag-env region (18)
individuals (n = 10)' donors (n = 6)
B lymphocytes 128 ± 34 140 ± 46
(number per jtl)
CD4/CD8 0.6 ± 0.3 1 .7 ± 0.4
IgG (mg/dl) 2,010 ± 450 1,089 ± 278
IgA (mg/dl) 436 ± 148 219 ± 89
IgM (mg/dl) 348 ± 104 200 ± 102
TNF-a (pg/ml)# 493 ± 207 23 ± 4.7
IL-6 (pg/ml)# 536 ± 226 18 ± 5.4can exert a direct effect on B lymphocyte proliferation and
differentiation. In some HIV-infected individuals, but none
of the seronegative controls, we observed an enhancingeffect
ofrecombinant gp120on theability ofBcells to secrete virus-
inducing cytokines(P. Rieckmann et al., unpublished obser-
vation). It is thereforeconceivable that HIV antigen-presenting
follicular dendritic cells, present in the lymph nodes of HIV
infected individuals, can activate B cells in vivo to secrete
cytokines that then upregulate virus expression in infected
cells of the follicle and paracortical regions in a paracrine
manner. In addition to its potential role in the regulation
of HIV expression, the constitutive production of TNF-a
and IL-6 by B cells may also explain in part the elevated Ig
levels observed in these patients. In fact, both cytokines are
involved in the proliferation and differentiation of B lym-
phocytes (10, 19), and an autocrine mechanism of B cell
differentiation has been recently proposed for IL-6 (10) . In
addition, we have observed spontaneous TNF-a and IL-6
production in Bcellsfrom patients with SLEwhowere hyper-
gammaglobulinemic. On the other hand, B cells from three
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failed to spontaneously secrete HIV-inductive cytokines (P.
Rieckmann et al., unpublished observation). Furthermore,
direct effects of B lymphocytes on the induction of T cell
abnormalities can also occur, and a recent report (20) has
demonstrated that T lymphocyte dysfunction in a murine
retrovirus-induced immunodeficiency syndrome is dependent
on the presence of mature B cells.
In conclusion, our findings that in vivo activated B cells
from HIV-infected individuals are able to upregulate HIV
expression by constitutively secreting TNF-a and IL-6 focus
on the importance of B cell activation during the progres-
sion of HIV infection. Chronic antigenic stimulation of B
cells mayaccountnot only for thehigh Ig levels seen in HIV
infected individuals, but may also directly contribute to the
expression of virus. These findings have important implica-
tions not only in the delineation of the scope of pathogenic
mechanisms of HIV infection, but also may serve as a basis
forthe design of therapeutic regimens targeted to this process.
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